Latham & Watkins Advises on Air Transport Services Group’s Convertible Senior Notes Offering. Air Transport Services Group, Inc. (NASDAQ: ATSG) has announced the pricing of its...
You must be a Standard 1 Year member to access this content.
Holland & Knight advised Savara, and Cooley advised the underwriters. Savara announced on July 13, 2023, the pricing of an underwritten offering of 21,000,000 shares of...
You must be a Standard 1 Year member to access this content.
Proskauer Rose advised Intapp, Latham & Watkins advised the underwriters, Sidley Austin advised Great Hill Equity Partners IV, L.P. and its affiliates, and Morrison & Foerster...
You must be a Standard 1 Year member to access this content.
Mintz advised the syndicate of underwriters on the deal. Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the underwriters and placements agents in the transaction. Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, has announced...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised the initial purchasers on the deal. Sarepta Therapeutics, Inc. announced its Rule 144A offering of 1.25% Convertible Senior Notes due 2027. The $1.15 billion...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, development and global access to life-changing...
You must be a Standard 1 Year member to access this content.
Lowenstein represented BTIG, LLC, Oppenheimer & Co. Inc., and B. Riley Securities, Inc. as sales agents in the offering. Celularity, Inc. executed an at-the-market offering of up...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the initial purchasers in the offering while Cooley advised Cytokinetics. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, has announced the pricing of its...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agents in the offering. ChargePoint Holdings, Inc. finalized a $500 million SEC-registered at-the-market offering of its common stock. ChargePoint’s common stock is...
You must be a Standard 1 Year member to access this content.
Cooley advised AN2 Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. AN2 Therapeutics, Inc. announced its upsized initial public offering of...
You must be a Standard 1 Year member to access this content.
Gornitzky represented Oppenheimer in the deal. MediWound Ltd., a biopharmaceutical company, executed a U.S. $10 million underwritten follow-on public offering of ordinary shares on Nasdaq. MediWound develops, manufactures and...
You must be a Standard 1 Year member to access this content.
